Published in Proc Natl Acad Sci U S A on April 27, 1999
Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect (2005) 17.71
Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine (Lond) (2008) 4.08
Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. Proc Natl Acad Sci U S A (2006) 3.86
PET imaging of soluble yttrium-86-labeled carbon nanotubes in mice. PLoS One (2007) 1.43
Behavioral and physiological changes in Daphnia magna when exposed to nanoparticle suspensions (titanium dioxide, nano-C60, and C60HxC70Hx). Environ Sci Technol (2007) 1.25
Medicine on a small scale. EMBO Rep (2003) 1.14
Destroying gadofullerene aggregates by salt addition in aqueous solution of Gd@C(60)(OH)(x) and Gd@C(60)[C(COOH(2))](10). J Am Chem Soc (2005) 1.11
Cage connectivity and frontier π orbitals govern the relative stability of charged fullerene isomers. Nat Chem (2015) 1.06
Molecular mechanism of pancreatic tumor metastasis inhibition by Gd@C82(OH)22 and its implication for de novo design of nanomedicine. Proc Natl Acad Sci U S A (2012) 1.03
Advances of cancer therapy by nanotechnology. Cancer Res Treat (2009) 1.01
[Gd@C(82)(OH)(22)](n) nanoparticles induce dendritic cell maturation and activate Th1 immune responses. ACS Nano (2010) 1.00
Inhalation Exposure to Carbon Nanotubes (CNT) and Carbon Nanofibers (CNF): Methodology and Dosimetry. J Toxicol Environ Health B Crit Rev (2015) 0.98
Biopharmaceutics and therapeutic potential of engineered nanomaterials. Curr Drug Metab (2008) 0.97
Emerging role of radiolabeled nanoparticles as an effective diagnostic technique. EJNMMI Res (2012) 0.96
Applications of functionalized fullerenes in tumor theranostics. Theranostics (2012) 0.93
Molecular dynamics analysis of a buckyball-antibody complex. Proc Natl Acad Sci U S A (2002) 0.90
Toxicity of Nanoparticles and an Overview of Current Experimental Models. Iran Biomed J (2015) 0.87
The studies on the aromaticity of fullerenes and their holmium endohedral compounds. J Mol Model (2010) 0.82
Interaction and protection mechanism between Li@C(60) and nucleic acid bases (NABs): performance of PM6-DH2 on noncovalent interaction of NABs-Li@C60. J Comput Chem (2011) 0.81
Evaluation of extraction methods for quantification of aqueous fullerenes in urine. Anal Bioanal Chem (2010) 0.79
Biomedical activities of endohedral metallofullerene optimized for nanopharmaceutics. J Nanosci Nanotechnol (2010) 0.79
Exohedral and endohedral adsorption of alkaline earth cations in BN nanocluster. J Mol Model (2012) 0.78
The applications of buckminsterfullerene C60 and derivatives in orthopaedic research. Connect Tissue Res (2014) 0.78
Single- and double-walled carbon nanotubes enhance atherosclerogenesis by promoting monocyte adhesion to endothelial cells and endothelial progenitor cell dysfunction. Part Fibre Toxicol (2016) 0.76
Cell Internalization Studies of Gadofullerene-(ZME-018) Immunoconjugates into A375m Melanoma Cells. Transl Oncol (2011) 0.75
A platform for specific delivery of lanthanide-scandium mixed-metal cluster fullerenes into target cells. ChemistryOpen (2012) 0.75
[Gd@C(82)(OH)(22)](n) nanoparticles inhibit the migration and adhesion of glioblastoma cells. Oncol Lett (2010) 0.75
Cytotoxic Effects of Hydroxylated Fullerenes in Three Types of Liver Cells. Materials (Basel) (2013) 0.75
Zn(II) released from zinc oxide nano/micro particles suppresses vasculogenesis in human endothelial colony-forming cells. Toxicol Rep (2015) 0.75
Carboxyfullerenes as neuroprotective agents. Proc Natl Acad Sci U S A (1997) 2.05
In vivo biological behavior of a water-miscible fullerene: 14C labeling, absorption, distribution, excretion and acute toxicity. Chem Biol (1995) 1.69
Buckminsterfullerenol free radical scavengers reduce excitotoxic and apoptotic death of cultured cortical neurons. Neurobiol Dis (1996) 1.57
Grafted poly-(ethylene glycol) on lipid surfaces inhibits protein adsorption and cell adhesion. Biochim Biophys Acta (1997) 1.26
Antigenicity of fullerenes: antibodies specific for fullerenes and their characteristics. Proc Natl Acad Sci U S A (1998) 1.25
Synthesis and virucidal activity of a water-soluble, configurationally stable, derivatized C60 fullerene. Antimicrob Agents Chemother (1993) 1.23
A bioactive fullerene peptide. J Med Chem (1994) 1.21
Pharmacokinetics of a water-soluble fullerene in rats. Antimicrob Agents Chemother (1996) 1.10
Neutron-activated holmium-166-poly (L-lactic acid) microspheres: a potential agent for the internal radiation therapy of hepatic tumors. J Nucl Med (1991) 1.08
[Study of the biological activity of the water-soluble fullerene complexes]. Dokl Akad Nauk (1997) 1.04
A novel promoting action of fullerene C60 on the chondrogenesis in rat embryonic limb bud cell culture system. Biochem Biophys Res Commun (1995) 0.99
Liposomes as MR contrast agents: pros and cons. Magn Reson Med (1991) 0.93
Radiolabeling antibodies with holmium-166. Appl Radiat Isot (1997) 0.90
Phagocytic activity of the liver as a measure of hepatic circulation--a comparative study using 198 Au and 99m Tc-sulfur colloid. J Nucl Med (1971) 0.89
Inhibitory effects of a fullerene derivative, dimalonic acid C60, on nitric oxide-induced relaxation of rabbit aorta. Eur J Pharmacol (1997) 0.88
[166Dy]dysprosium/[166Ho]holmium in vivo generator. Appl Radiat Isot (1995) 0.83
Comparison of the biodistribution of gadolinium-153 DTPA and technetium-99m DTPA in rats. J Nucl Med (1988) 0.83
Comparison of immunological effects of Fullerene C60 and raw soot from Fullerene production on alveolar macrophages and macrophage like cells in vitro. Exp Toxicol Pathol (1996) 0.83
HEPATIC BLOOD FLOW DETERMINED BY COLLOIDAL GOLD CLEARANCE COMPARED WITH DIRECT FLOW MEASUREMENTS. J Nucl Med (1964) 0.81
Bone marrow transplantation in dogs after radio-ablation with a new Ho-166 amino phosphonic acid bone-seeking agent (DOTMP). Blood (1993) 0.81
Experimental validation of radiopharmaceutical absorbed dose to mineralized bone tissue. Appl Radiat Isot (1993) 0.81
High resolution X-ray computed tomography: an emerging tool for small animal cancer research. Neoplasia (2000) 3.22
Integrin alpha 6/beta 4 complex is located in hemidesmosomes, suggesting a major role in epidermal cell-basement membrane adhesion. J Cell Biol (1991) 2.88
Transformation of Aspergillus nidulans with the hygromycin-resistance gene, hph. Gene (1987) 2.48
The anti-hepatitis B virus activities, cytotoxicities, and anabolic profiles of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine. Antimicrob Agents Chemother (1992) 2.38
A novel membrane antigen selectively expressed on terminally differentiated human B cells. Blood (1994) 2.27
Superparamagnetic gadonanotubes are high-performance MRI contrast agents. Chem Commun (Camb) (2005) 2.05
The alpha 6 beta 1 (VLA-6) and alpha 6 beta 4 protein complexes: tissue distribution and biochemical properties. J Cell Sci (1990) 1.83
Properties of an oncornavirus glycoprotein: evidence for its presence on the surface of virions and infected cells. Virology (1973) 1.71
Karyotypic, virologic, and immunologic analyses of two continuous lymphocyte lines established from New Zealand black mice: possible relationship of chromosomal mosaicism to autoimmunity. Proc Natl Acad Sci U S A (1972) 1.65
Evaluation of 225Ac for vascular targeted radioimmunotherapy of lung tumors. Cancer Biother Radiopharm (2000) 1.62
Isolation and characterization of plasma membrane associated immunoglobulin from cultured human diploid lymphocytes. J Mol Biol (1973) 1.56
Characterization of Fv-1 host range strains of murine retroviruses by titration and p30 protein characteristics. Virology (1979) 1.55
Sexual and marital problems in a psychiatric out-patient population. Br J Psychiatry (1979) 1.43
Use of yttrium-90-labeled anti-Tac antibody in primate xenograft transplantation. Transplantation (1990) 1.41
Expression of tumor antigen correlated with metastatic potential of Lewis lung carcinoma and B16 melanoma clones in mice. Cancer Res (1986) 1.29
Monoclonal antibody to human carcinoma-associated protein complex: quantitation in normal and tumor tissue. Cancer Res (1988) 1.20
Interactions of immunoliposomes with target cells. J Biol Chem (1983) 1.16
Expression of beta 1, beta 3, beta 4, and beta 5 integrins by human lung carcinoma cells of different histotypes. Exp Cell Res (1994) 1.11
Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminals to monoclonal antibodies. Biochim Biophys Acta (1995) 1.11
Production and immunodiagnostic applications of antihuman light chain monoclonal antibodies. Am J Clin Pathol (1993) 1.07
Distinct substrate preference of human and mouse N-methylpurine-DNA glycosylases. Carcinogenesis (1996) 1.06
On the monohene character of cytochromes c'. Proc Natl Acad Sci U S A (1972) 1.05
Distribution of viral glycoprotein gp 69/71 on cell surfaces of producer and nonproducer cells. Cancer Res (1976) 1.04
Binding of monoclonal antibody to protein antigen in fluid phase or bound to solid supports. J Immunol Methods (1982) 1.04
The role of tin in the direct labelling of proteins with Rhenium-188. Nucl Med Biol (1997) 1.03
Improved production of chymosin in Aspergillus by expression as a glucoamylase-chymosin fusion. Biotechnology (N Y) (1990) 1.02
Improved in vivo stability and tumor targeting of bismuth-labeled antibody. Cancer Res (1990) 1.02
Lipid composition is important for highly efficient target binding and retention of immunoliposomes. Proc Natl Acad Sci U S A (1990) 1.02
Monoclonal antibody covalently coupled with fatty acid. A reagent for in vitro liposome targeting. J Biol Chem (1980) 1.01
Radioimmunotherapy of micrometastases in lung with vascular targeted 213Bi. Br J Cancer (1999) 1.00
Radiotoxicity of bismuth-213 bound to membranes of monolayer and spheroid cultures of tumor cells. Radiat Res (1999) 0.99
Molecular cloning and deletion of the gene encoding aspergillopepsin A from Aspergillus awamori. Gene (1990) 0.97
Nature of the bifunctional chelating agent used for radioimmunotherapy with yttrium-90 monoclonal antibodies: critical factors in determining in vivo survival and organ toxicity. Cancer Res (1989) 0.97
Vascular targeted radioimmunotherapy with 213Bi--an alpha-particle emitter. Nucl Med Biol (1998) 0.95
Physical parameters and biological stability of yttrium(III) diethylenetriaminepentaacetic acid derivative conjugates. J Med Chem (1998) 0.95
Integrin (alpha 6/beta 4) expression in human lung cancer as monitored by specific monoclonal antibodies. Cancer Res (1990) 0.95
Targeted therapy of athymic mice bearing GW-39 human colonic cancer micrometastases with 131I-labeled monoclonal antibodies. Cancer Res (1992) 0.95
An epidemiologic study of fatigue with relevance for the chronic fatigue syndrome. J Psychiatr Res (1997) 0.93
A direct measurement of dynamic spin-interconversion rates in the spin-equilibrium protein ferric myoglobin hydroxide. J Am Chem Soc (1977) 0.92
Sequence and centromere proximal location of a transformation enhancing fragment ans1 from Aspergillus nidulans. Nucleic Acids Res (1987) 0.92
Acrylamide and iodide fluorescence quenching as a structural probe of tryptophan microenvironment in bovine lens crystallins. Curr Eye Res (1986) 0.92
In vivo evaluation of bismuth-labeled monoclonal antibody comparing DTPA-derived bifunctional chelates. Cancer Biother Radiopharm (2001) 0.92
Vascular-targeted radioimmunotherapy with the alpha-particle emitter 211At. Radiat Res (2002) 0.91
Radiolabeling antibodies with holmium-166. Appl Radiat Isot (1997) 0.90
211At radiocolloid therapy: further observations and comparison with radiocolloids of 32P, 165Dy, and 90Y. Int J Radiat Oncol Biol Phys (1984) 0.90
Pharmacokinetics and bioactivity of 1,4,7,10-tetra-azacylododecane off',N'',N'''-tetraacetic acid (DOTA)-bismuth-conjugated anti-Tac antibody for alpha-emitter (212Bi) therapy. Cancer Res (1993) 0.90
Ligand-induced phosphorylation of a murine tumor surface protein (TSP-180) associated with metastatic phenotype. Cancer Res (1989) 0.90
Characterization of in vivo immunoliposome targeting to pulmonary endothelium. J Pharm Sci (1990) 0.89
Improved in vivo stability of actinium-225 macrocyclic complexes. J Med Chem (1999) 0.88
Affinity labeling of rabbit antibodies to the 2,4,6 trinitrophenyl determinant. Immunochemistry (1970) 0.88
Cloning, characterization, and expression of two alpha-amylase genes from Aspergillus niger var. awamori. Curr Genet (1990) 0.88
Characterization of antibody covalently coupled to liposomes. Biochim Biophys Acta (1982) 0.88
Analysis of proteins of mouse sarcoma pseudotype viruses: type-specific radioimmunoassay for ecotropic virus p30's. J Virol (1979) 0.87
Medically safe rate of weight loss for the treatment of obesity: a guideline based on risk of gallstone formation. Am J Med (1995) 0.86
Primary structure of Mucor miehei aspartyl protease: evidence for a zymogen intermediate. Gene (1986) 0.86
Comparison of 225actinium chelates: tissue distribution and radiotoxicity. Nucl Med Biol (1999) 0.86
Reactor-produced radioisotopes from ORNL for bone pain palliation. Appl Radiat Isot (1998) 0.86
Binding of immunoglobulin G to phospholipid vesicles by sonication. Biochemistry (1979) 0.86
A comparative study of the biochemical properties of human and mouse recombinant O6-methylguanine-DNA methyltransferases. Carcinogenesis (1995) 0.86
Distribution of a tumor cell surface protein common to several murine lung carcinomas. Cancer Res (1980) 0.85
Treatment of lung tumor colonies with 90Y targeted to blood vessels: comparison with the alpha-particle emitter 213Bi. Nucl Med Biol (1999) 0.85
Use of Aspergillus overproducing mutants, cured for integrated plasmid, to overproduce heterologous proteins. Appl Microbiol Biotechnol (1993) 0.85
Antibodies to mouse lung capillary endothelium. J Histochem Cytochem (1988) 0.85
Observations on light-induced oxidation reactions in the electron transport system of Chromatium. Biophys J (1972) 0.84
Characterization of organ-specific immunoliposomes for delivery of 3',5'-O-dipalmitoyl-5-fluoro-2'-deoxyuridine in a mouse lung-metastasis model. Cancer Chemother Pharmacol (1995) 0.84
Simple new method for effective concentration of 188Re solutions from alumina-based 188W-188Re generator. J Nucl Med (2000) 0.83
[166Dy]dysprosium/[166Ho]holmium in vivo generator. Appl Radiat Isot (1995) 0.83
Thrombomodulin is preferentially expressed in Balb/c lung microvessels. J Biol Chem (1992) 0.83
Comparative biodistributions of yttrium- and indium-labeled monoclonal antibody B72.3 in athymic mice bearing human colon carcinoma xenografts. J Nucl Med (1989) 0.83
Tumor antigen on benign adenomas and on murine lung carcinomas quantitated by a two-site monoclonal antibody assay. Cancer Res (1986) 0.83
Stimulation of tumor cell growth in vitro by a monoclonal antibody to a tumor specific protein (TSP-180) present on the cell surface of 3LL cells. Clin Exp Metastasis (1989) 0.83
Analysis of surface proteins of mouse lung carcinomas using monoclonal antibodies. Cancer Res (1981) 0.82
An intracisternal A-particle DNA sequence is closely linked to the thrombomodulin gene in some strains of laboratory mice. DNA Cell Biol (1993) 0.82
Direct binding of radioiodinated monoclonal antibody to tumor cells: significance of antibody purity and affinity for drug targeting or tumor imaging. Hybridoma (1983) 0.82
Examination of the macronuclear replication band in Euplotes eurystomus with monoclonal antibodies. J Cell Biol (1986) 0.82
Iron-containing proteins in Chromatium. II. Purification and properties of cholate-solubilized cytochrome complex. Biochim Biophys Acta (1971) 0.82
Heterogeneity and clonal variation related to cell surface expression of a mouse lung tumor-associated antigen quantified using flow cytometry. Cancer Res (1984) 0.81
Detection of circulating tumor antigens in mice carrying a highly metastatic pulmonary squamous--cell carcinoma. Int J Cancer (1978) 0.81
Salt-induced aggregation of lysozyme studied by cross-linking with glutaraldehyde: implications for crystal growth. Acta Crystallogr D Biol Crystallogr (1996) 0.81
Iron-containing proteins in Chromatium. I. Solubilization of membrane-bound cytochrome. Biochim Biophys Acta (1971) 0.81
Low cost polymer intramedullary nails for fracture fixation: a biomechanical study in a porcine femur model. Arch Orthop Trauma Surg (2009) 0.80
Highly efficient immunoliposomes prepared with a method which is compatible with various lipid compositions. Biochem Biophys Res Commun (1989) 0.80
Demonstration of cellular and humoral immunity to transplantable carcinomas derived from the respiratory tract of rats. Cancer Res (1978) 0.80
Intratumoral injection of rhenium-188 microspheres into an animal model of hepatoma. J Nucl Med (1998) 0.79
Molecular stereochemistry of [FeIII(TPP)(OCOCF3)]. Acta Crystallogr C (1995) 0.79
Analysis for TNF-alpha using solid-phase affinity capture with radiolabel and MALDI-MS detection. Anal Chem (1999) 0.79
Isolation and comparison of murine leukemia virus-related glycoproteins from AKR and New Zealand mice. J Virol (1977) 0.79
The development of Aspergillus niger var. awamori as a host for the expression and secretion of heterologous gene products. Biochem Soc Trans (1991) 0.79
Monoclonal antibodies to CD44 epitopes on mouse endothelium. Hybrid Hybridomics (2002) 0.79
Considerations involving paramagnetic coordination compounds as useful NMR contrast agents. Int J Rad Appl Instrum B (1988) 0.79
Simultaneous determination of enantioselective plasma protein binding of aminohydantoins by ultrafiltration and chiral high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl (1999) 0.79
Combination vascular targeted and tumor targeted radioimmunotherapy. Cancer Biother Radiopharm (1999) 0.78
Rat monoclonal antibodies to mouse lung components for analysis of fibrosis. Exp Mol Pathol (1987) 0.78
Therapy of a murine sarcoma using syngeneic monoclonal antibody. Cancer Res (1983) 0.78
The continuing important role of radionuclide generator systems for nuclear medicine. Eur J Nucl Med (1994) 0.78
Monoclonal antibodies from rats immunized with fragment D of human fibrinogen. Thromb Res (1981) 0.78